20/09/2001 (Agence Europe) - In our article in the 17/18 September edition of EUROPE, please read: "Mr Lönngren explained that Bayer's anticholesterol product had been authorised by national authorities as part of the mutual recognition process and that the EMEA itself had not been involved in checking its safety. At the beginning of July, the EMEA launched an enquiry into the statin family (including Bayer's product) in order to find out how frequently undesirable side effects occurred,...